Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, MI, USA.
Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, MI, USA.
Environ Res. 2023 Jun 15;227:115813. doi: 10.1016/j.envres.2023.115813. Epub 2023 Mar 31.
Racial/ethnic disparities in hypertension are a pressing public health problem. The contribution of environmental pollutants including PFAS have not been explored, even though certain PFAS are higher in Black population and have been associated with hypertension.
We examined the extent to which racial/ethnic disparities in incident hypertension are explained by racial/ethnic differences in serum PFAS concentrations.
We included 1058 hypertension-free midlife women with serum PFAS concentrations in 1999-2000 from the multi-racial/ethnic Study of Women's Health Across the Nation with approximately annual follow-up visits through 2017. Causal mediation analysis was conducted using accelerated failure time models. Quantile-based g-computation was used to evaluate the joint effects of PFAS mixtures.
During 11,722 person-years of follow-up, 470 participants developed incident hypertension (40.1 cases per 1000 person-years). Black participants had higher risks of developing hypertension (relative survival: 0.58, 95% CI: 0.45-0.76) compared with White participants, which suggests racial/ethnic disparities in the timing of hypertension onset. The percent of this difference in timing that was mediated by PFAS was 8.2% (95% CI: 0.7-15.3) for PFOS, 6.9% (95% CI: 0.2-13.8) for EtFOSAA, 12.7% (95% CI: 1.4-22.6) for MeFOSAA, and 19.1% (95% CI: 4.2, 29.0) for PFAS mixtures. The percentage of the disparities in hypertension between Black versus White women that could have been eliminated if everyone's PFAS concentrations were dropped to the 10th percentiles observed in this population was 10.2% (95% CI: 0.9-18.6) for PFOS, 7.5% (95% CI: 0.2-14.9) for EtFOSAA, and 17.5% (95% CI: 2.1-29.8) for MeFOSAA.
These findings suggest differences in PFAS exposure may be an unrecognized modifiable risk factor that partially accounts for racial/ethnic disparities in timing of hypertension onset among midlife women. The study calls for public policies aimed at reducing PFAS exposures that could contribute to reductions in racial/ethnic disparities in hypertension.
高血压的种族/民族差异是一个紧迫的公共卫生问题。尽管某些全氟辛酸 (PFAS) 在黑人群体中含量较高,并与高血压有关,但包括 PFAS 在内的环境污染物造成的差异尚未得到探索。
我们研究了种族/民族间血清 PFAS 浓度差异在多大程度上解释了高血压发病的种族/民族差异。
我们纳入了来自多种族/民族女性健康研究的 1058 名高血压前期中年女性,这些女性在 1999-2000 年时血清中含有 PFAS,通过大约每年一次的随访,直到 2017 年。使用加速失效时间模型进行因果中介分析。使用基于分位数的 g 计算来评估 PFAS 混合物的联合效应。
在 11722 人年的随访期间,有 470 名参与者发生了高血压(每 1000 人年 40.1 例)。与白人参与者相比,黑人参与者发生高血压的风险更高(相对生存率:0.58,95%CI:0.45-0.76),这表明高血压发病时间存在种族/民族差异。PFAS 解释了这种时间差异的 8.2%(95%CI:0.7-15.3)为全氟辛烷磺酸(PFOS),6.9%(95%CI:0.2-13.8)为 EtFOSAA,12.7%(95%CI:1.4-22.6)为 MeFOSAA,19.1%(95%CI:4.2,29.0)为 PFAS 混合物。如果每个人的 PFAS 浓度降低到该人群中观察到的第 10 个百分位数,那么黑人和白人女性之间高血压差异的 10.2%(95%CI:0.9-18.6)可以归因于 PFOS,7.5%(95%CI:0.2-14.9)归因于 EtFOSAA,17.5%(95%CI:2.1-29.8)归因于 MeFOSAA。
这些发现表明,PFAS 暴露的差异可能是一个未被认识到的可改变的风险因素,部分解释了中年女性高血压发病时间的种族/民族差异。该研究呼吁采取旨在减少 PFAS 暴露的公共政策,这可能有助于减少高血压的种族/民族差异。